60 Degrees Pharmaceuticals, Inc.
SXTP
$0.97
$0.00-0.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.39% | -45.22% | 37.89% | -33.60% | 7.61% |
| Total Depreciation and Amortization | 18.92% | 9.75% | 3.51% | 15.74% | 17.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 183.13% | 59.26% | -188.38% | 57.92% | 20.45% |
| Change in Net Operating Assets | 81.78% | -2,183.83% | 116.66% | -446.42% | -43.44% |
| Cash from Operations | 18.60% | -61.99% | 19.75% | -45.45% | 9.22% |
| Capital Expenditure | 100.00% | 62.45% | -699.00% | 78.86% | -1,651.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.03% | 194.81% | -8,226.45% | -252.27% | -100.26% |
| Cash from Investing | -107.21% | 187.10% | -5,274.12% | 50.68% | -103.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 634.80% | -89.29% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 634.80% | -89.29% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -55.93% | 521.43% | -216.67% | -93.02% | 273.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.67% | 170.14% | -221.26% | 244.74% | -182.84% |